Ophthalmology, Retina Specialist · Los Angeles, CA
NPI
1710093182
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
4220 W 3rd St, Suite 206
Los Angeles, CA, 90020
Phone (213) 380-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
8,790 services
Medicare patients, 2024
698
Average age 78
Drug cost, 2024
$2.7M
9,446 prescriptions
Company payments, 2025
$1,857
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hans H Kim was code 92012 (ophthalmological e&m), 1,655 times for 495 patients. In total Hans H Kim billed 8,790 services in 59 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 1,655 | 495 | $75.54 | $125K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,033 | 77 | $659.15 | $681K |
| 67028 Intravitreal Injection | Office | 590 | 88 | $49.19 | $29K |
| 92273 Test - Miscellaneous | Office | 587 | 437 | $111.01 | $65K |
| 65800 Fluid Flow and Drainage of Eye (Any Method) | Office | 585 | 89 | $101.26 | $59K |
| 92134 Computerized Ophthalmic Imaging | Office | 558 | 127 | $35.37 | $20K |
| 92014 Ophthalmological E&M | Office | 539 | 399 | $100.85 | $54K |
| 92250 Angiography | Office | 537 | 423 | $28.42 | $15K |
| 68761 Eye | Office | 365 | 258 | $191.34 | $70K |
| 92083 Vision, Hearing, and Speech Services | Office | 306 | 299 | $53.80 | $16K |
| 92201 Ophthalmological E&M | Office | 281 | 257 | $20.90 | $5,872 |
| 92235 Angiography | Office | 229 | 219 | $146.56 | $34K |
| 76512 Ultrasound - Nonspecific | Office | 197 | 99 | $38.01 | $7,489 |
| 65210 Eye | Office | 158 | 123 | $40.06 | $6,330 |
| 76513 Ultrasound - Nonspecific | Office | 95 | 93 | $64.02 | $6,082 |
By year: 2022 $1.5M for 9,629 services; 2023 $1.2M for 8,506 services; 2024 $1.3M for 8,790 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hans H Kim prescribed most often to Medicare patients was Latanoprost, with 1,804 prescriptions and refills. In total Hans H Kim wrote 9,446 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,804 | 3,196 | 436 | $15K |
| Timolol Maleate Generic | 1,248 | 2,576 | 366 | $11K |
| Restasis Cyclosporine | 1,116 | 1,466 | 296 | $920K |
| Azelastine Hcl Generic | 515 | 726 | 217 | $7,810 |
| Moxifloxacin Moxifloxacin Hcl | 510 | 513 | 222 | $10K |
| Cyclosporine Generic | 485 | 1,008 | 210 | $265K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 277 | 545 | 80 | $4,897 |
| Prednisolone Acetate Generic | 251 | 385 | 138 | $6,325 |
| Cequa Cyclosporine | 239 | 319 | 80 | $182K |
| Ketorolac Tromethamine Generic | 203 | 459 | 174 | $2,165 |
| Brimonidine Tartrate Generic | 202 | 314 | 50 | $9,214 |
| Miebo Perfluorohexyloctane/Pf | 194 | 272 | 78 | $219K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 189 | 265 | 40 | $94K |
| Combigan Brimonidine Tartrate/Timolol | 178 | 258 | 37 | $53K |
| Vyzulta Latanoprostene Bunod | 178 | 234 | 41 | $58K |
Brand drugs: 4,551 claims; generic drugs: 4,895 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hans H Kim $1,857 ($1,857 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $611.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $611 |
| Tarsus Pharmaceuticals, Inc. TARS | 7 | $274 |
| Bausch & Lomb Americas Inc. BLCO | 13 | $224 |
| Sight Sciences, Inc. SGHT | 7 | $216 |
| Alcon Vision LLC ALC | 5 | $147 |
| Nova Eye, Inc. | 1 | $99.5 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $85.59 |
| Dompe US, Inc. | 3 | $70.62 |
| Thea Pharma Inc. | 2 | $44.98 |
| Oyster Point Pharma, Inc. | 2 | $39.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.